This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. (REGN) shed 1.25% to $659.20 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 4.04% to 3,923.68 and Dow Jones Industrial Average falling 3.57% to 31,490.07. The stock's fall snapped a four-day winning streak. Regeneron Pharmaceuticals Inc. closed $88.22 short of its 52-week high ($747.42), which the company achieved on April 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson (JNJ) fell 1.86% to $175.50, Novartis AG ADR (NOVN.EB) fell 0.27% to $87.68, and Amgen Inc. (AMGN) fell 0.57% to $243.96. Trading volume (558,143) remained 108,889 below its 50-day average volume of 667,032.
Data source: Dow Jones Market Data, FactSet. Data compiled May 18, 2022.
(END) Dow Jones Newswires
May 18, 2022 17:18 ET (21:18 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.